Document is current
Any future updates will be listed below
-
Authors
Hernandez, Hernan https://orcid.org/0000-0002-0597-6059
Santamaria-Garcia, Hernando
Moguilner, Sebastian
Farina, Francesca R.
Legaz, Agustina
Prado, Pavel
Cuadros, Jhosmary
Gonzalez, Liset
Gonzalez-Gomez, Raul https://orcid.org/0000-0003-2341-011X
Migeot, Joaquín
Coronel-Oliveros, Carlos
Tagliazucchi, Enzo
Maito, Marcelo Adrián
Godoy, María E.
Cruzat, Josephine https://orcid.org/0000-0002-3252-8657
Shaheen, Ahmed
Farombi, Temitope
Salazar, Daniel
Da Ros, Lucas Uglione https://orcid.org/0009-0000-8187-9851
Borelli, Wyllians V. https://orcid.org/0000-0001-9282-0601
Zimmer, Eduardo R. https://orcid.org/0000-0002-5349-0053
Njamnshi, Alfred K.
Bajpai, Swati
Dey, A. B.
Mostert, Cyprian
Merali, Zul
Salama, Mohamed
Moustafa, Sara A.
Fittipaldi, Sol
Altschuler, Florencia https://orcid.org/0000-0001-6362-963X
Medel, Vicente
Huepe, David
Yaffe, Kristine
Momoh, Chinedu
Eyre, Harris A.
Swieboda, Pawel
Lawlor, Brian
Miranda, J. Jaime
Duran-Aniotz, Claudia
Baez, Sandra https://orcid.org/0000-0003-0875-1709
Ibanez, Agustin https://orcid.org/0000-0001-6758-5101
- License Information
-
More Information
Article History
Received: 27 December 2024
Accepted: 27 May 2025
First Online: 14 July 2025
Competing interests
: E.R.Z. has served on scientific advisory boards for Nintx, Novo Nordisk and Masima. He is also a cofounder and a minority shareholder at Masima. The other authors declare no competing interests.
